Intellia Therapeutics
NTLA
NTLA
85 hedge funds and large institutions have $439M invested in Intellia Therapeutics in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 85 → 85 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
58% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $3.71M
Holders
85
Holding in Top 10
1
Calls
$1.55M
Puts
$3.71M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$8.21M | |
| 3 | +$4.91M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.19M |
Top Sellers
| 1 | -$3.73M | |
| 2 | -$1.86M | |
| 3 | -$1.21M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.19M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.13M |